BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK
36 results:

  • 1. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with Ntrk and other kinase gene aberrations.
    Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
    J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ntrk-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::ntrk1 fusion.
    Szalai L; Vereczkey I; Szemes M; Rókusz A; Csernák E; Tóth E; Melegh Z
    Virchows Arch; 2024 Mar; 484(3):527-531. PubMed ID: 38151535
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pan-trk immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
    Moura MS; Costa J; Velasco V; Kommoss F; Oliva E; Le Loarer F; McCluggage WG; Razack R; Treilleux I; Mills A; Longacre T; Devouassoux-Shisheboran M; Hostein I; Azmani R; Blanchard L; Hartog C; Soubeyran I; Khalifa E; Croce S
    Histopathology; 2024 Feb; 84(3):451-462. PubMed ID: 37988282
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Natural history and treatment efficacy in an ambispective case series of Ntrk-rearranged mesenchymal tumors.
    Dufresne A; Pissaloux D; Ngo C; Penel N; Le Cesne A; Macagno N; Vanacker H; Hénon C; Jean-Denis M; Rughoo K; Tirode F; Blay JY; Brahmi M
    ESMO Open; 2023 Apr; 8(2):101202. PubMed ID: 37054503
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Postoperative venous thromboembolism risk stratification in patients with uterine cancer.
    Wagner VM; Piver RN; Levine MD; Backes FJ; Chambers LJ; Cohn DE; Copeland LJ; Cosgrove CM; Nagel CI; O'Malley DM; Bixel KL
    Am J Obstet Gynecol; 2023 May; 228(5):555.e1-555.e8. PubMed ID: 36574873
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adenoid Basal Carcinoma with Adenoid Cystic Carcinoma Component of the uterine Cervix: A Case Report and Literature Review.
    Kitamura SI; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2023 Aug; 31(5):819-824. PubMed ID: 36452999
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ntrk -Rearranged uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
    Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
    Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
    Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adult Ntrk-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
    Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ntrk-Fusion Sarcoma of the uterine Cervix: Report of 2 Cases With Comparative Clinicopathologic Features.
    Nilforoushan N; Wethington SL; Nonogaki H; Gross J; Vang R; Xing D
    Int J Gynecol Pathol; 2022 Nov; 41(6):642-648. PubMed ID: 34723848
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes.
    Acosta AM; Sholl LM; Dickson BC; McKenney JK; Gordetsky JB; Pins MR; Marino-Enriquez A; Dong F; Dubuc AM; Cin PD; Fletcher CDM
    Mod Pathol; 2021 Sep; 34(9):1763-1779. PubMed ID: 33986460
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spitz nevus with a novel TFG-Ntrk2 fusion: The first case report of Ntrk2-rearranged Spitz/Reed nevus.
    Goto K; Pissaloux D; Tirode F; de la Fouchardière A
    J Cutan Pathol; 2021 Sep; 48(9):1193-1196. PubMed ID: 33979462
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Metastatic leiomyosarcoma of the thyroid: A rare entity.
    Che Jalil NA; Rama Chandran P; Samsudin AHZ; Yahya MM; Wan Abdul Rahman WF
    Malays J Pathol; 2021 Apr; 43(1):69-73. PubMed ID: 33903308
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Basaloid Squamous Cell Carcinoma of the uterine Cervix: Report of a Case With Molecular Analysis.
    Munkhdelger J; Shimooka T; Koyama Y; Ikeda S; Mikami Y; Fukuoka J; Hori T; Bychkov A
    Int J Surg Pathol; 2021 Oct; 29(7):770-774. PubMed ID: 33792431
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Neurofibrosarcoma Revisited: An Institutional Case Series of uterine Sarcomas Harboring Kinase-related Fusions With Report of a Novel FGFR1-TACC1 Fusion.
    Devereaux KA; Weiel JJ; Mills AM; Kunder CA; Longacre TA
    Am J Surg Pathol; 2021 May; 45(5):638-652. PubMed ID: 33481389
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. S100 and Pan-trk Staining to Report Ntrk Fusion-Positive uterine Sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
    Chiang S
    Int J Gynecol Pathol; 2021 Jan; 40(1):24-27. PubMed ID: 33290352
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix.
    Cimic A; Vranic S; Arguello D; Contreras E; Gatalica Z; Swensen J
    Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):299-304. PubMed ID: 33208671
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. p53 immunohistochemical analysis of fusion-positive uterine sarcomas.
    Mohammad N; Stewart CJR; Chiang S; Turashvili G; Dickson BC; Ng TL; Köbel M; McCluggage WG; Croce S; Lee CH
    Histopathology; 2021 May; 78(6):805-813. PubMed ID: 33118176
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
    Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
    Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic Profiling Aids Classification of Diagnostically Challenging uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
    Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
    Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.